Development and Application of Intelligent Assessment System of Longshi Scale

The purpose of this study was to verify convenience and feasibility of the novel intelligent Longshi assessment system to provide an accurate and convenient evaluation tool for stroke survivors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Disability Physical Nervous System Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Shenzhen Second People's Hospital

Shenzhen, Guangdong, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion Criteria:

Stroke survivors

age≥18 years
diagnosis of cerebral infraction or intracerebral hemorrhage
stable vital signs
willingness to participate in the study with informed consent
Professional evaluators:

One to ten years of working experience
experience in rehabilitation scientific research or education related work for more than two years
association with Longshi Scale research
Non-professional evaluators：

the family or caregiver of stroke survivors
ability to read and communicate
willingness to participate in the study with informed consent
Exclusion Criteria:

Stroke survivors:

brain tumor, Parkinson's disease or active epilepsy within past three months
impaired cognitive functions
participation in any other clinical study
Professional evaluators:

refusal to participate in the study
Non-professional evaluators:

care for patients with serious mental health problems
refusal to participate in the study

Treatment and study plan

Primary outcomes

Consistency of the disability degree evaluated using the electronic version and the paper version of Longshi Scale

Time frame: Within 48 hours

Weighted kappa was used to determine the consistency of the disability degree evaluated using the electronic version and the paper version of Longshi Scale. Kappa value ranges from 0 to 1 and the thresholds for kappa reliability are as follows: poor (κ = 0.00-0.20), fair (κ= 0.21-0.40), moderate (κ = 0.41-0.60), good (κ = 0.61-0.80),and very good (κ = 0.81-1.00).

Secondary outcomes

Proportion of evaluators' preference

Time frame: Within 48 hours

After completing all the evaluations, each evaluator was asked to reveal their preferred version (paper version, electronic version or no preference). Chi-square test was used to compare the proportion of evaluators' preference.
Time required

Time frame: Within 48 hours

Time required in each section of electronic version and paper version of Longshi Scale.
Test-retest reliability of electronic version Longshi Scale

Time frame: Within 48 hours after first evaluation

Weighted kappa was used to determine test-retest reliability of electronic version Longshi Scale. Kappa value ranges from 0 to 1 and the thresholds for kappa reliability are as follows: poor (κ = 0.00-0.20), fair (κ= 0.21-0.40), moderate (κ = 0.41-0.60), good (κ = 0.61-0.80),and very good (κ = 0.81-1.00).

Sponsors and collaborators

Lead sponsor

Shenzhen Second People's Hospital

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Jan 31, 2022
Registry last updated: Jan 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed